Industry
Researchers
Clinicians
Patients & Families
Advocacy Groups
PrOSPeCT
Our Programs
PROGRAMS
Cancer Screening Program (CaSP)
Bringing comprehensive genomic profiling to patients with advanced and incurable cancer
Molecular Screening and Therapeutics (MoST) study
Using the power of genomic technology to characterise molecular changes in a patient's cancer
Surveillance study in Multi-Organ Cancer prone syndromes (SMOC+)
Investigating and evaluating the surveillance practices used for people at high-risk of multi-organ cancer
Genetic Cancer Risk in the Young (RisC) study – Now closed
Understanding the genetic variants that contribute to inherited cancer
CLINICAL TRIALS
Company Studies (C3)
Companion Studies (C2)
MoST Core Studies (C1)
MoST-LLy
ASPiRATION
Resources & Events
About Us
About Us
Network & Partners
Our Board
Our Leadership Team
Publications
Annual Reports
Partner Toolkits
News
Contact
Partner Toolkits
Resources & Events
About Us
Network & Partners
Our Board
Our Leadership Team
Publications
Annual Reports
News
Contact
Sign up for newsletter
About Us
Annual Reports
2024
Annual Report 2024
2023
Annual Report 2023
2022
Annual Report 2022
2021
Annual report 2021
2020
Annual Report 2020
2019
Annual report 2019
